View all dosages and compare prices:
💊 Buy Mounjaro — all dosages →
Buy Mounjaro 2.5 mg
Weight loss program start — body adaptation
in Ukraine · Original Eli Lilly (UK) · Thermobox delivery
💊 Try for 8 000 ₴/mo
4 individual doses instead of a full pen · save 9 000 ₴
Ships today · before 19:00
Delivery Sat, Jun 27 · Nova Poshta
Starter Mounjaro pen 2.5 mg for beginning your weight loss program. Minimum dose for gentle body adaptation to tirzepatide.
Starting dose. Minimal risk of discomfort. After 4 weeks, your specialist will increase the dose to 5 mg.
Specialist support included in the price
A personal DOZA specialist supports you throughout the entire course — from the first consultation to results. No extra fees: support is already included in the product price.
DOZA offers the original UK version of Mounjaro 2.5 mg
Eli Lilly and Company Limited (United Kingdom), registered by MHRA for the UK market. Not Indian generics, not the US version (FDA), not Chinese copies. You can verify authenticity by the serial number on the packaging.
Why specifically the UK version? After incidents with DE and ES supply chains — where storage conditions were compromised and clients didn't achieve expected results — we chose exclusively the British Eli Lilly supply chain. It has the strictest post-Brexit transport controls for GLP-1 products.
Free specialist consultation
Benefits of Mounjaro 2.5 mg
- ✓Gentle body adaptation — minimal discomfort risk
- ✓Appetite reduction from first days of treatment
- ✓Expected result: -2 to -4 kg in the first month
- ✓Original Eli Lilly product with verified serial number
- ✓Convenient KwikPen — 30-second application
- ✓24/7 DOZA specialist support
Mounjaro 2.5 mg — detailed description
Mounjaro 2.5 mg is the starting dose of the original Eli Lilly product for the first month of your body contouring program. The KwikPen contains 4 doses of 2.5 mg tirzepatide — one application per week.
This dose is designed for gentle body adaptation to the dual action of GLP-1 and GIP receptors. Most DOZA clients notice significant appetite reduction from the first days of treatment.
During the first month (4 weeks) on the starting dose, DOZA clients lose on average 2 to 4 kg. After successful adaptation, the specialist increases the dose to 5 mg to enhance the effect.
How Mounjaro 2.5 mg works — tirzepatide mechanism of action
Tirzepatide at 2.5 mg dose activates GLP-1 and GIP receptors — two key pathways for appetite and metabolism regulation. Even at minimum dose, the dual mechanism provides:
• Appetite reduction through hypothalamic action
• Delayed gastric emptying — food provides satiety feeling longer
• Beginning of fat reserve mobilization through GIP receptors
The starting dose allows the body to gradually adapt to the product, minimizing discomfort risk.
Clinical research
Mounjaro (tirzepatide 2.5 mg) — FDA approved 2022. Dual GLP-1 + GIP agonist. The /research page contains the full evidence base: SURMOUNT-1 / SURPASS-2 / FDA prescribing information.
- SURMOUNT-1: Tirzepatide once weekly for the treatment of obesity (NEJM 2022)PubMed · 2022
- SURPASS-2: Tirzepatide vs semaglutide in type 2 diabetes (NEJM 2021)PubMed · 2021
- FDA prescribing information — Mounjaro (tirzepatide)FDA prescribing information · 2022
Titration protocol to 2.5 mg (tirzepatide)
The only FDA-approved starting dose
Injection once weekly, subcutaneous (abdomen, thigh or upper arm). Expected weight loss at 2.5 mg: 3–4% in the first month (based on clinical studies).
Who is Mounjaro 2.5 mg for
- Starting Mounjaro therapy — the mandatory first step for all patients
- Gastrointestinal adaptation before moving up to 5 mg
- Patients with increased sensitivity to GLP-1 medications
Mounjaro 2.5 mg — compared to other doses
- 2.5 mg is a starting dose: the goal of the first month is adaptation, not maximum effect
- After 4 weeks it must be increased to 5 mg
- Average weight loss on 2.5 mg: 3–4% in the first month (SURMOUNT-1)
Frequently asked questions about Mounjaro 2.5 mg
The starting dose of 2.5 mg allows the body to adapt to tirzepatide with minimal discomfort risk. This is Eli Lilly's manufacturer recommendation and standard protocol. Moving directly to higher doses is not recommended.
Anastasia Shapoval
Metabolic Programs and Weight Control Specialist
Weight loss program — step-by-step dose escalation
DOZA client reviews for Mounjaro 2.5 mg
Mounjaro 2.5 mg — felt results in 3 weeks. Lost 4 kg in the first month. Thermobox delivery, excellent quality. DOZA — support throughout the entire course.
Ordering Mounjaro 2.5 mg for the second time. Original Eli Lilly quality, fair price. DOZA — highly recommend.
All Mounjaro client results →
Before/after photos · numbers · timelines · reviews
Other Mounjaro dosages
Mounjaro 2.5 mg — buy in Ukraine from DOZA
Mounjaro 2.5 mg (Mounjaro 2,5 mg, tirzepatide) — original KwikPen by Eli Lilly for weight loss programs. Price 17 000 ₴ (≈ 4 250 ₴ per injection). Buy Mounjaro 2.5 mg in Ukraine through the DOZA online service with delivery within 1–2 days in a thermobox (cold chain 2–8°C).
Why does DOZA only work with the UK version? We stopped working with DE and ES versions after cases when clients didn't achieve expected results — likely due to storage condition violations during transport. The UK supply chain of Eli Lilly has the strictest quality control among European markets. Each KwikPen has a serial number verifiable on the manufacturer's official website.
Mounjaro 2.5 mg is suitable for weeks 1-4 of the tirzepatide protocol. Tirzepatide works through a dual GLP-1 + GIP mechanism — reducing appetite and improving glucose metabolism. The SURMOUNT-1 clinical trial showed up to 20% weight loss over 72 weeks.
DOZA offers exclusively the Mounjaro Made in U.K. version. Mounjaro 2.5 mg delivery across Ukraine (Kyiv, Kharkiv, Odesa, Dnipro, Lviv) by Nova Poshta or courier in a thermobox. Free specialist consultation and support throughout the entire course included.
⚠️ This information is for educational purposes only and does not constitute advertising of medicinal products. We recommend obtaining an individual specialist consultation before starting a program. Results may vary depending on individual characteristics. Mounjaro® is a registered trademark of Eli Lilly and Company.